LU91220I2 - Tipranavir ou un de ses sels pharmaceutiques (aptivus) - Google Patents

Tipranavir ou un de ses sels pharmaceutiques (aptivus)

Info

Publication number: LU91220I2
Authority: LU; Luxembourg
Prior art keywords: aptivus; tipranavir; ones; pharmaceutical salt; pyran
Prior art date: 1994-05-06

Application number

LU91220C

Other languages

English (en)

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-06

Filing date

2006-02-08

Publication date

2006-04-10

2006-02-08 Application filed by Upjohn Co filed Critical Upjohn Co

2006-04-10 Publication of LU91220I2 publication Critical patent/LU91220I2/fr

Links

SUJUHGSWHZTSEU-FYBSXPHGSA-N tipranavir Chemical compound C([C@@]1(CCC)OC(=O)C([C@H](CC)C=2C=C(NS(=O)(=O)C=3N=CC(=CC=3)C(F)(F)F)C=CC=2)=C(O)C1)CC1=CC=CC=C1 SUJUHGSWHZTSEU-FYBSXPHGSA-N 0.000 title 2
SUJUHGSWHZTSEU-UHFFFAOYSA-N Tipranavir Natural products C1C(O)=C(C(CC)C=2C=C(NS(=O)(=O)C=3N=CC(=CC=3)C(F)(F)F)C=CC=2)C(=O)OC1(CCC)CCC1=CC=CC=C1 SUJUHGSWHZTSEU-UHFFFAOYSA-N 0.000 title 1
229940030139 aptivus Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
229960000838 tipranavir Drugs 0.000 title 1
241001430294 unidentified retrovirus Species 0.000 abstract 2
QBDAFARLDLCWAT-UHFFFAOYSA-N 2,3-dihydropyran-6-one Chemical class O=C1OCCC=C1 QBDAFARLDLCWAT-UHFFFAOYSA-N 0.000 abstract 1
ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 abstract 1
VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical class C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
210000004962 mammalian cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

LU91220C 1994-05-06 2006-02-08 Tipranavir ou un de ses sels pharmaceutiques (aptivus) LU91220I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23881794A	1994-05-06	1994-05-06
US34936194A	1994-12-02	1994-12-02

Publications (1)

Publication Number	Publication Date
LU91220I2 true LU91220I2 (fr)	2006-04-10

Family

ID=26931995

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91220C LU91220I2 (fr)	1994-05-06	2006-02-08	Tipranavir ou un de ses sels pharmaceutiques (aptivus)

Country Status (32)

Country	Link
US (2)	US5852195A (fr)
EP (1)	EP0758327B1 (fr)
JP (1)	JP3883206B2 (fr)
KR (1)	KR100445929B1 (fr)
CN (2)	CN1154642C (fr)
AT (1)	ATE236894T1 (fr)
AU (2)	AU701965B2 (fr)
BR (1)	BR9507615A (fr)
CA (2)	CA2560489C (fr)
CO (1)	CO4810313A1 (fr)
CZ (1)	CZ296515B6 (fr)
DE (2)	DE69530294T2 (fr)
DK (1)	DK0758327T3 (fr)
ES (1)	ES2192201T3 (fr)
FI (1)	FI117387B (fr)
FR (1)	FR05C0047I2 (fr)
HU (1)	HU228057B1 (fr)
IL (3)	IL129871A (fr)
LU (1)	LU91220I2 (fr)
MX (1)	MX9605391A (fr)
MY (2)	MY127701A (fr)
NL (1)	NL300216I2 (fr)
NO (2)	NO315799B1 (fr)
NZ (1)	NZ285510A (fr)
PE (1)	PE23196A1 (fr)
PL (1)	PL190540B1 (fr)
PT (1)	PT758327E (fr)
RU (1)	RU2139284C1 (fr)
SI (1)	SI0758327T1 (fr)
SK (1)	SK284407B6 (fr)
TW (1)	TW504507B (fr)
WO (1)	WO1995030670A2 (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL129871A (en) *	1994-05-06	2003-11-23	Pharmacia & Upjohn Inc	Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5914332A (en)	1995-12-13	1999-06-22	Abbott Laboratories	Retroviral protease inhibiting compounds
DE69724964T2 (de) *	1996-07-03	2004-07-22	Pharmacia & Upjohn Co., Kalamazoo	Zielgerichte arzneimittel abgabe für zulphonamide-derivate
US5834506A (en) *	1996-11-01	1998-11-10	Warner-Lambert Company	Dihydropyrones with improved antiviral activity
US6232333B1 (en)	1996-11-21	2001-05-15	Abbott Laboratories	Pharmaceutical composition
DK0999838T3 (da) *	1997-07-29	2002-07-08	Upjohn Co	Selv-emulgerende formulering for lipofile forbindelser
JP4524367B2 (ja)	1997-07-29	2010-08-18	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	自己乳化性処方形態の酸性親油性化合物用の医薬組成物
SI0999826T1 (en) *	1997-07-29	2004-12-31	Pharmacia & Upjohn Company	Self-emulsifying formulation for lipophilic compounds
DK1015441T3 (da) *	1997-09-11	2004-07-26	Upjohn Co	Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer
ATE226579T1 (de) *	1999-03-18	2002-11-15	Upjohn Co	Verbesserte verfahren fur assymmetrische hydrogenation
US6956048B2 (en) *	1999-03-31	2005-10-18	Pharmacia & Upjohn Company	Pharmaceutical emulsions for retroviral protease inhibitors
ES2676151T3 (es)	2000-01-19	2018-07-17	Abbvie Inc.	Formulaciones farmacéuticas mejoradas
FI113942B (fi) *	2000-08-18	2004-07-15	Control Ox Oy	Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
DE10108470A1 (de) *	2001-02-22	2002-09-05	Boehringer Ingelheim Pharma	Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en)	2001-02-22	2002-12-31	Boehringer Ingelheim Pharma Kg	Process for preparing optically active dihydropyrones
MXPA04007809A (es) *	2002-02-25	2004-10-15	Kudos Pharm Ltd	Piranonas utiles como inhibidores de ataxia-telangetaxia mutada.
AU2003215826A1 (en) *	2002-04-01	2003-10-13	Pfizer Inc.	Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
RU2234535C2 (ru) *	2002-10-03	2004-08-20	Государственный научный центр вирусологии и биотехнологии "Вектор"	Субстрат для определения активности интегразы вируса иммунодефицита человека
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8377952B2 (en)	2003-08-28	2013-02-19	Abbott Laboratories	Solid pharmaceutical dosage formulation
US8841326B2 (en)	2004-02-12	2014-09-23	Stc.Unm	Therapeutic curcumin derivatives
IL161586A (en) *	2004-04-22	2015-02-26	Rafael Advanced Defense Sys	Irreplaceable energetic material and reactive shielding that uses it
EP1812069A2 (fr) *	2004-11-08	2007-08-01	Boehringer Ingelheim International GmbH	Methode de traitement d'infection vih par coadministration de tipranavir et etravirine
US20060135562A1 (en) *	2004-11-16	2006-06-22	Boehringer Ingelheim International Gmbh	Method for treating HIV infection through co-administration of tipranavir and darunavir
EP1814549A2 (fr) *	2004-11-19	2007-08-08	Boehringer Ingelheim International GmbH	Traitement de l'infection a vih par co-administration de tipranavir et d'uk-427, 857
US20060128733A1 (en) *	2004-11-19	2006-06-15	Boehringer Ingelheim International Gmbh	Method for treating HIV infection through co-administration of tipranavir and reverset
WO2006060177A1 (fr) *	2004-12-01	2006-06-08	Boehringer Ingelheim International Gmbh	Methode de traitement de l'infection a vih par co-administration de tipranavir et de gw873140
JP2008521896A (ja) *	2004-12-01	2008-06-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チプラナビル及びｇｗ６９５６３４を共に投与することを含むｈｉｖ感染症の治療方法
WO2006060175A1 (fr) *	2004-12-01	2006-06-08	Boehringer Ingelheim International Gmbh	Procede de traitement d'une infection par le vih par co-administration de tipranavir et de sch-417690
WO2008112289A2 (fr)	2007-03-12	2008-09-18	Nektar Therapeutics	Conjugués d'oligomère-inhibiteur de protéase
US20090062346A1 (en) *	2007-08-29	2009-03-05	Protia, Llc	Deuterium-enriched tipranavir
EP2203420A1 (fr) *	2007-09-25	2010-07-07	Merck Sharp & Dohme Corp.	Inhibiteurs de la protease du vih
KR101076680B1 (ko) *	2007-11-01	2011-10-26	한미홀딩스 주식회사	(6ｒ)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체
EP2262498A2 (fr) *	2008-03-10	2010-12-22	Vertex Pharmceuticals Incorporated	Pyrimidines et pyridines utiles comme inhibiteurs des protéines kinases
WO2009114151A1 (fr)	2008-03-12	2009-09-17	Nektar Therapeutics	Conjugués oligomères-acides aminés et oligomères-atazanavir
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
MX2011006890A (es)	2008-12-23	2011-07-20	Pharmasset Inc	Analogos de nucleosidos.
CL2009002206A1 (es)	2008-12-23	2011-08-26	Gilead Pharmasset Llc	Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es)	2008-12-23	2011-02-23	Pharmasset Inc	Fosforamidatos de nucleosidos
CA2762582A1 (fr)	2009-05-27	2010-12-02	Merck Sharp & Dohme Corp.	Inhibiteurs de la protease du vih
EP2440249A2 (fr)	2009-06-12	2012-04-18	Nektar Therapeutics	Conjugués covalents comprenant un inhibiteurs de protéase, un oligomère non-peptidique soluble dans l'eau et une partie lipophilique
GEP20207129B (en)	2009-06-17	2020-07-10	Vertex Pharma	Inhibitors of influenza viruses replication
KR101466245B1 (ko) *	2010-01-15	2014-12-01	한미사이언스 주식회사	테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
AP2012006535A0 (en)	2010-03-31	2012-10-31	Gilead Pharmasset Llc	Stereoselective synthesis of phosphorous containing actives
WO2012033846A1 (fr)	2010-09-09	2012-03-15	Rutgers, The State University Of New Jersey	Agents antibactériens à base d'arylpropionyl-tricétone
WO2012033815A1 (fr) *	2010-09-09	2012-03-15	Rutgers, The State University Of New Jersey	Agents anti-bactériens à base d'arylpropionyl-alpha-pyrone
WO2012037508A2 (fr)	2010-09-17	2012-03-22	Rutgers, The State University Of New Jersey	Agents antibactériens : dérivés de myxopyronine de puissance élevée
US9079834B2 (en)	2010-10-28	2015-07-14	Merck Canada Inc.	HIV protease inhibitors
RU2013132681A (ru)	2010-12-16	2015-01-27	Вертекс Фармасьютикалз Инкорпорейтед	Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) *	2011-08-01	2018-11-12	Вертекс Фармасьютікалз Інкорпорейтед	Інгібітори реплікації вірусів грипу
US9133157B2 (en)	2011-10-26	2015-09-15	Merck Canada Inc.	HIV protease inhibitors
WO2013103969A1 (fr)	2012-01-05	2013-07-11	Rutgers, The State University Of New Jersey	Agents antibactériens : dérivés du phloroglucinol
JP2015527403A (ja) *	2012-09-11	2015-09-17	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Ｈｉｖプロテアーゼ阻害剤
US9227990B2 (en)	2012-10-29	2016-01-05	Cipla Limited	Antiviral phosphonate analogues and process for preparation thereof
WO2015013835A1 (fr)	2013-07-31	2015-02-05	Merck Sharp & Dohme Corp.	Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
HUE038820T2 (hu)	2013-11-13	2018-11-28	Vertex Pharma	Eljárás influenzavírusok replikációjának inhibitorai elõállítására
PT3068776T (pt)	2013-11-13	2019-08-26	Vertex Pharma	Inibidores da replicação de vírus da gripe
WO2015095265A1 (fr)	2013-12-19	2015-06-25	Merck Sharp & Dohme Corp.	Inhibiteurs de la protéase du vih
WO2015095276A1 (fr)	2013-12-19	2015-06-25	Merck Sharp & Dohme Corp.	Inhibiteurs de la protéase du vih
US9994587B2 (en)	2014-03-06	2018-06-12	Merck Sharp & Dohme Corp.	HIV protease inhibitors
WO2015138220A1 (fr)	2014-03-10	2015-09-17	Merck Sharp & Dohme Corp.	Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
US9738664B2 (en)	2014-10-29	2017-08-22	Wisconsin Alumni Research Foundation	Boronic acid inhibitors of HIV protease
EP3294717B1 (fr)	2015-05-13	2020-07-29	Vertex Pharmaceuticals Inc.	Procédés de préparation d'inhibiteurs de réplication des virus de la grippe
WO2016183120A1 (fr)	2015-05-13	2016-11-17	Vertex Pharmaceuticals Incorporated	Inhibiteurs de la réplication des virus de la grippe
US10450292B2 (en)	2015-12-10	2019-10-22	Rutgers, The State University of New Jersesy	Inhibitors of bacterial RNA polymerase: arylpropanoyl, arylpropenoyl, and arylcyclopropanecarboxyl phloroglucinols
WO2017156458A1 (fr)	2016-03-11	2017-09-14	University Of South Florida	Inhibiteurs de bêta-lactamases, formulations et utilisations correspondantes
US11993590B2 (en) *	2016-12-04	2024-05-28	712 North Inc.	Pyranone compounds useful to modulate OMA1 protease
CN112118837B (zh)	2018-02-13	2024-07-09	罗格斯新泽西州立大学	抗菌剂：o-烷基氘化派洛宁
US12209082B2 (en)	2018-02-13	2025-01-28	Rutgers, The State University Of New Jersey	Antibacterial agents: soluble salts and aqueous formulations of pyronins
US11572337B2 (en)	2018-03-06	2023-02-07	Rutgers, The State University Of New Jersey	Antibacterial agents: arylalkylcarboxamido phloroglucinols
CN110551090B (zh) *	2019-10-21	2021-06-18	扬州工业职业技术学院	一种超声波提取中药狗脊中抗肿瘤活性成分的方法
WO2021209563A1 (fr)	2020-04-16	2021-10-21	Som Innovation Biotech, S.A.	Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire
TW202430153A (zh) *	2022-12-16	2024-08-01	美商戴納立製藥公司	化合物、組成物及方法
CN116730993B (zh) *	2023-04-25	2026-01-23	浙江科技学院	一种替拉那韦中间体及替拉那韦的制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB193507A (en)	1921-11-25	1923-02-26	English Electric Co Ltd	Improvements in and connected with hydraulic impulse turbines
NL80964C (fr) *	1952-03-08
NL83407C (fr) *	1952-05-16
US2723277A (en) *	1952-08-26	1955-11-08	Hoffmann La Roche	Malonic acid derivatives and process for the manufacture thereof
US2872457A (en) *	1956-04-19	1959-02-03	Wisconsin Alumni Res Found	Process for the preparation of 4-hydroxycoumarin derivatives
GB836740A (en) *	1956-04-25	1960-06-09	Bayer Ag	Coumarin derivatives and their production
FR1276654A (fr) *	1958-10-01	1961-11-24		Nouveaux dérivés de l'hydroxy-4-alpha-2-pyrone
FR1463767A (fr) *	1963-04-03	1966-07-22	Clin Byla Ets	Dérivés de la coumarine et leur préparation
BE674997A (fr) *	1965-01-13	1966-07-12
FR1559595A (fr) *	1966-12-13	1969-03-14
US3489774A (en) *	1967-04-24	1970-01-13	Dow Chemical Co	3-(beta-aryl-beta-(arylthio) (or arylseleno) propionyl)-coumarin products
US3493586A (en) *	1969-01-23	1970-02-03	Dow Chemical Co	3-(beta-aryl-beta-(arylthio) (or arylseleno)-propionyl)pyrone products
JPS4823942B1 (fr) *	1969-02-14	1973-07-17
US3764693A (en) *	1969-11-21	1973-10-09	Lipha	A rodenticidal compositions containing 4-hydroxy coumarins
US3835161A (en) *	1972-10-24	1974-09-10	Realisations Scient S E Res C	3-substituted-4-hydroxy-coumarins
US3931235A (en) *	1972-12-18	1976-01-06	The Dow Chemical Company	Process for preparing sulfur-containing hydroxy pyrones
JPS53147073A (en) *	1977-05-24	1978-12-21	Sankyo Co Ltd	Mevalonolactone derivatives
NZ194557A (en) *	1979-08-17	1984-09-28	Merck & Co Inc	Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
CA1171424A (fr) *	1981-06-17	1984-07-24	Alvin K. Willard	( )-(4r, 6s) - (e)-6-[2-(4'fluoro-3,3', 5-trimethyl- [1,1'-biphenyle]-2-yl)ethenyle]-3,4,5,6- tetrahydro-4-hydroxy-2h-pyran-2-one
JPS634652A (ja) *	1986-06-25	1988-01-09	Hitachi Ltd	半導体装置
AU1044088A (en)	1986-12-17	1988-07-15	Nippon Soda Co., Ltd.	Heterocyclic compounds having triketo skeleton
US4900754A (en) *	1987-12-21	1990-02-13	Rorer Pharmaceutical Corp.	HMG-COA reductase inhibitors
EP0403535A1 (fr) *	1988-03-01	1990-12-27	The Upjohn Company	Coumarines permettant d'inhiber la transcriptase inverse chez les etres humains
DE3929913A1 (de) *	1989-09-08	1991-04-04	Hoechst Ag	4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
JPH05503073A (ja) *	1989-09-26	1993-05-27	オクタマー，インコーポレイテッド	ウイルス性疾患の治療に有用な６―アミノ―１，２―ベンゾピロン
JPH05501879A (ja) *	1989-10-27	1993-04-08	ジ・アップジョン・カンパニー	Ｈｉｖおよび他のレトロウイルスを処理する方法およびそれに有用な化合物
JPH03227923A (ja)	1990-01-30	1991-10-08	Sawai Seiyaku Kk	ひと免疫不全ウイルス疾患処置剤
SE9000624D0 (sv) *	1990-02-22	1990-02-22	Pharmacia Ab	New use
CA2035972C (fr) *	1990-02-23	2006-07-11	Martin Karpf	Procede de preparation d'oxetanones
AU8665991A (en) *	1990-09-07	1992-03-30	Schering Corporation	Antiviral compounds and antihypertensive compounds
EP0547145A1 (fr) *	1990-09-07	1993-06-23	Schering Corporation	2(1h)-quinolinone composes antiviraux
US5378694A (en) *	1990-09-07	1995-01-03	Schering Corporation	Acyl and alkoxy substituted quinolines
US5484951A (en) *	1990-10-19	1996-01-16	Octamer, Incorporated	5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
EP0578745A1 (fr) *	1991-04-04	1994-01-19	The Upjohn Company	Composes contenant du phosphore et servant d'inhibiteurs de retrovirus
KR100268694B1 (ko) *	1991-10-11	2000-10-16	미리암 디. 메코너헤이, 블레어큐. 퍼거슨	레트로바이러스 프로테아제 억제제로 유용한 시클릭 우레아 및 유사체
JP3070767B2 (ja) *	1991-10-22	2000-07-31	オクタマー，インコーポレイティド	抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物
DE4308451A1 (de) *	1992-09-10	1994-04-14	Bayer Ag	3-Aryl-pyron-Derivate
ZA938019B (en) *	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) *	1993-02-05	1994-04-12	Opjohn Company	4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IL129871A (en) *	1994-05-06	2003-11-23	Pharmacia & Upjohn Inc	Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

1995
- 1995-05-01 IL IL12987195A patent/IL129871A/xx not_active IP Right Cessation
- 1995-05-04 AT AT95918864T patent/ATE236894T1/de active
- 1995-05-04 BR BR9507615A patent/BR9507615A/pt active Search and Examination
- 1995-05-04 MX MX9605391A patent/MX9605391A/es active IP Right Grant
- 1995-05-04 CZ CZ0317296A patent/CZ296515B6/cs not_active IP Right Cessation
- 1995-05-04 US US08/809,224 patent/US5852195A/en not_active Expired - Lifetime
- 1995-05-04 KR KR1019960706245A patent/KR100445929B1/ko not_active Expired - Lifetime
- 1995-05-04 DK DK95918864T patent/DK0758327T3/da active
- 1995-05-04 NZ NZ285510A patent/NZ285510A/en not_active IP Right Cessation
- 1995-05-04 CN CNB951935534A patent/CN1154642C/zh not_active Expired - Lifetime
- 1995-05-04 RU RU96123286A patent/RU2139284C1/ru active
- 1995-05-04 SK SK1384-96A patent/SK284407B6/sk not_active IP Right Cessation
- 1995-05-04 ES ES95918864T patent/ES2192201T3/es not_active Expired - Lifetime
- 1995-05-04 EP EP95918864A patent/EP0758327B1/fr not_active Expired - Lifetime
- 1995-05-04 CA CA002560489A patent/CA2560489C/fr not_active Expired - Lifetime
- 1995-05-04 CA CA002187523A patent/CA2187523C/fr not_active Expired - Lifetime
- 1995-05-04 PT PT95918864T patent/PT758327E/pt unknown
- 1995-05-04 TW TW084104473A patent/TW504507B/zh not_active IP Right Cessation
- 1995-05-04 SI SI9530660T patent/SI0758327T1/xx unknown
- 1995-05-04 AU AU24626/95A patent/AU701965B2/en not_active Expired
- 1995-05-04 HU HU9603074A patent/HU228057B1/hu active Protection Beyond IP Right Term
- 1995-05-04 DE DE69530294T patent/DE69530294T2/de not_active Expired - Lifetime
- 1995-05-04 WO PCT/US1995/005219 patent/WO1995030670A2/fr not_active Ceased
- 1995-05-04 JP JP52901695A patent/JP3883206B2/ja not_active Expired - Lifetime
- 1995-05-04 CN CNB2004100346805A patent/CN1329378C/zh not_active Expired - Lifetime
- 1995-05-04 PL PL95317061A patent/PL190540B1/pl unknown
- 1995-05-04 DE DE1995630294 patent/DE122006000014I2/de active Active
- 1995-05-05 CO CO95018810A patent/CO4810313A1/es unknown
- 1995-05-05 MY MYPI95001195A patent/MY127701A/en unknown
- 1995-05-05 MY MYPI20051072A patent/MY149862A/en unknown
- 1995-05-08 PE PE1995268036A patent/PE23196A1/es not_active IP Right Cessation
1996
- 1996-05-01 IL IL11356796A patent/IL113567A/xx not_active IP Right Cessation
- 1996-11-05 FI FI964441A patent/FI117387B/fi not_active IP Right Cessation
- 1996-11-05 NO NO19964676A patent/NO315799B1/no not_active IP Right Cessation
1998
- 1998-11-09 US US09/188,998 patent/US6169181B1/en not_active Expired - Lifetime
1999
- 1999-04-09 AU AU23686/99A patent/AU718117B2/en not_active Expired
- 1999-05-10 IL IL12987199A patent/IL129871A0/xx unknown
2005
- 2005-12-22 FR FR05C0047C patent/FR05C0047I2/fr active Active
2006
- 2006-01-20 NL NL300216C patent/NL300216I2/nl unknown
- 2006-02-08 LU LU91220C patent/LU91220I2/fr unknown
- 2006-03-02 NO NO2006003C patent/NO2006003I2/no unknown

Also Published As

Publication number	Publication date
SI0758327T1 (en)	2003-08-31
NO964676L (no)	1997-01-06
HK1066796A1 (zh)	2005-04-01
KR100445929B1 (ko)	2005-09-30
FI964441A0 (fi)	1996-11-05
RU2139284C1 (ru)	1999-10-10
PL317061A1 (en)	1997-03-03
MY127701A (en)	2006-12-29
AU2462695A (en)	1995-11-29
AU718117B2 (en)	2000-04-06
TW504507B (en)	2002-10-01
DE69530294D1 (de)	2003-05-15
ES2192201T3 (es)	2003-10-01
KR970702858A (ko)	1997-06-10
EP0758327A1 (fr)	1997-02-19
SK284407B6 (sk)	2005-03-04
CA2187523A1 (fr)	1995-11-16
IL129871A0 (en)	2000-02-29
CN1154642C (zh)	2004-06-23
DE69530294T2 (de)	2003-12-24
US6169181B1 (en)	2001-01-02
MY149862A (en)	2013-10-31
CZ317296A3 (en)	1997-04-16
DE122006000014I1 (de)	2006-11-16
CN1539825A (zh)	2004-10-27
HK1084667A1 (en)	2006-08-04
CZ296515B6 (cs)	2006-04-12
HU228057B1 (en)	2012-09-28
IL113567A (en)	2003-05-29
WO1995030670A2 (fr)	1995-11-16
DK0758327T3 (da)	2003-07-28
NO964676D0 (no)	1996-11-05
NO315799B1 (no)	2003-10-27
ATE236894T1 (de)	2003-04-15
WO1995030670A3 (fr)	1996-04-25
FR05C0047I2 (fr)	2007-10-19
MX9605391A (es)	1997-12-31
AU701965B2 (en)	1999-02-11
NO2006003I1 (no)	2006-03-13
CO4810313A1 (es)	1999-06-30
PE23196A1 (es)	1996-06-07
CN1150424A (zh)	1997-05-21
HU9603074D0 (en)	1997-01-28
NL300216I2 (nl)	2006-06-01
CN1329378C (zh)	2007-08-01
JPH09512821A (ja)	1997-12-22
IL129871A (en)	2003-11-23
SK138496A3 (en)	1997-06-04
PL190540B1 (pl)	2005-12-30
CA2560489C (fr)	2010-01-12
DE122006000014I2 (de)	2007-03-29
HUT77601A (hu)	1998-06-29
CA2187523C (fr)	2006-11-21
AU2368699A (en)	1999-06-03
NZ285510A (en)	1998-03-25
NL300216I1 (nl)	2006-04-03
US5852195A (en)	1998-12-22
BR9507615A (pt)	1997-09-09
FI117387B (fi)	2006-09-29
JP3883206B2 (ja)	2007-02-21
PT758327E (pt)	2003-08-29
EP0758327B1 (fr)	2003-04-09
NO2006003I2 (no)	2008-10-20
CA2560489A1 (fr)	1995-11-16
FR05C0047I1 (fr)	2006-03-10
FI964441L (fi)	1996-11-05

Publication	Publication Date	Title
MY127701A (en)	2006-12-29	Pyranone compounds useful to treat retroviral infections
AU603525B2 (en)	1990-11-15	Tetrazole intermediates to antihypertensive compounds
MY119031A (en)	2005-03-31	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
NO953070D0 (no)	1995-08-04	4-hydroksy-benzopyran-2-oner og 4-hydroksysykloalkyl[BÅpyran-2-oner anvendbare for behandling av retrovirusinfeksjoner
TR199700844T1 (xx)	1998-01-21	Pirazolil-Benzoil T�revleri.
DE69637380D1 (en)	2008-02-07	Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
TR200800474T2 (tr)	2008-04-21	Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
ATE196913T1 (de)	2000-10-15	Neuartige peptidderivate
FI910366A0 (fi)	1991-01-24	Menetelmä deoksimulundokandiinin valmistamiseksi
SU666804A1 (ru)	1998-07-10	S-метилсульфониевые соли 3,5-дифенил-2-тиабицикло[4,4,0] декана или дец-5-ена, проявляющие антимикробную активность